Up to 70 million doses of vaccine needed for mass vaccination of the population of Russia from the coronavirus. The country’s leadership and organization of health care already are taking steps to start industrial production of the protective drug. This was stated by the Director, National research centre of epidemiology and Microbiology them. N. F. Gamalei Alexander Ginzburg.

"Now there are clinical trials of the vaccine. If successful, the result is not excluded that by the autumn we will start the production of the drug", – quotes the Director of the center newspaper "Red star".

The expert noted that the immunity received from the medicine will protect the body from COVID-19 for at least two years. Will also be vaccinated twice. One gene is expected to be medium. This approach will allow us to extend that immunity. Previously the method has confirmed its effectiveness for the development of vaccines against Ebola virus. That drug against the coronavirus SARS-CoV-2 made exactly on the same principle, gives reason to expect a prolonged protective effect, said Alexander Ginzburg.